Sundowning syndrome in aging and dementia: Research in mouse models
暂无分享,去创建一个
[1] J. Brioni,et al. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. , 1993, European journal of pharmacology.
[2] D. O'Connor,et al. A survey of Australian and New Zealand old age psychiatrists' preferred medications to treat behavioral and psychological symptoms of dementia (BPSD) , 2005, International Psychogeriatrics.
[3] D. Kunz,et al. Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy. , 2004, Journal of clinical psychopharmacology.
[4] B. Costall,et al. Muscarinic antagonists are anxiogenic in rats tested in the black-white box , 1996, Pharmacology Biochemistry and Behavior.
[5] S. Ancoli-Israel,et al. Illumination levels in nursing home patients: effects on sleep and activity rhythms , 2000, Journal of sleep research.
[6] R. Nelson,et al. Potential animal models of seasonal affective disorder , 2011, Neuroscience & Biobehavioral Reviews.
[7] Van Someren EJ. Circadian and sleep disturbances in the elderly. , 2000, Experimental gerontology.
[8] N. Kutner,et al. Observed sleep/wakefulness and severity of dementia in an Alzheimer's disease special care unit. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.
[9] Rochelle E Tractenberg,et al. The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease , 2003, Journal of sleep research.
[10] Kristine Yaffe,et al. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. , 2003, JAMA.
[11] J R Hodges,et al. Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. , 2004, Brain : a journal of neurology.
[12] W N Charman,et al. Age, lens transmittance, and the possible effects of light on melatonin suppression. , 2003, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.
[13] Dick F Swaab,et al. Melatonin rhythmicity: effect of age and Alzheimer's disease , 2003, Experimental Gerontology.
[14] D. Pfaff,et al. Definition of Arousal and Mechanistic Studies in Intact and Brain‐Damaged Mice , 2009, Annals of the New York Academy of Sciences.
[15] S. Tufik,et al. Anxiogenic effect of sleep deprivation in the elevated plus-maze test in mice , 2004, Psychopharmacology.
[16] G. Stoppe,et al. Treatment of rest‐activity disorders in dementia and special focus on sundowning , 2005, International journal of geriatric psychiatry.
[17] Sonia Ancoli-Israel,et al. Increased Light Exposure Consolidates Sleep and Strengthens Circadian Rhythms in Severe Alzheimer's Disease Patients , 2003, Behavioral sleep medicine.
[18] A. Cadete-Leite,et al. Basal forebrain neurons modulate the synthesis and expression of neuropeptides in the rat suprachiasmatic nucleus , 2004, Neuroscience.
[19] Gary L. Wenk,et al. The Nucleus Basalis Magnocellularis Cholinergic System: One Hundred Years of Progress , 1997, Neurobiology of Learning and Memory.
[20] Shelley Peacock,et al. Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementia. , 2009, The Cochrane database of systematic reviews.
[21] T. Balkin,et al. The effects of sleep deprivation on symptoms of psychopathology in healthy adults. , 2007, Sleep medicine.
[22] D. Coakley,et al. BEHAVIOUR DISTURBANCE AND OTHER PREDICTORS OF CARER BURDEN IN ALZHEIMER'S DISEASE , 1997, International journal of geriatric psychiatry.
[23] C. Pollak,et al. Sleep Problems and Institutionalization of the Elderly , 1991, Journal of geriatric psychiatry and neurology.
[24] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[25] S. Klaffke,et al. Sundowning and circadian rhythm disorders in dementia. , 2006, Acta neurologica Belgica.
[26] G. Stoppe,et al. Behavioural Problems Associated With Dementia , 1999, Drugs & aging.
[27] S. Borson,et al. Sleep Disturbances in Patients with Alzheimer’s Disease , 2001, CNS drugs.
[28] B. Rovner,et al. Sedative-hypnotic use by the elderly: Effects on hospital length of stay and costs , 1997, The journal of mental health administration.
[29] S. Henriksen,et al. Age-independent and age-related deficits in visuospatial learning, sleep–wake states, thermoregulation and motor activity in PDAPP mice , 2002, Brain Research.
[30] D. Cardinali,et al. Clinical Aspects of Melatonin Intervention in Alzheimer’s Disease Progression , 2010, Current neuropharmacology.
[31] M. Biel,et al. Melanopsin and rod–cone photoreceptive systems account for all major accessory visual functions in mice , 2003, Nature.
[32] B. C. Manning,et al. Sundowning and circadian rhythms in Alzheimer's disease. , 2001, The American journal of psychiatry.
[33] L. Evans. Sundown Syndrome in Institutionalized Elderly , 1987, Journal of the American Geriatrics Society.
[34] Dov Zohar,et al. The effects of sleep loss on medical residents' emotional reactions to work events: a cognitive-energy model. , 2005, Sleep.
[35] C. Colwell,et al. Age-Related Decline in Circadian Output , 2011, The Journal of Neuroscience.
[36] D. Rokicki,et al. The anxiolytic-like effect of nicotine undergoes rapid tolerance in a model of contextual fear conditioning in rats , 2001, Pharmacology Biochemistry and Behavior.
[37] C. Pollak,et al. Sleep problems in the community elderly as predictors of death and nursing home placement , 1990, Journal of Community Health.
[38] Raymond Cluydts,et al. The emotional brain and sleep: an intimate relationship. , 2010, Sleep medicine reviews.
[39] R. Nelson,et al. Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice , 2011, Proceedings of the National Academy of Sciences.
[40] S. File,et al. Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. , 1999, Behavioural pharmacology.
[41] D. Cameron. Studies in senile nocturnal delirium , 1941 .
[42] B. Sommer,et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[43] Kazuo Nakamura,et al. Scopolamine model of delirium in rats and reversal of the performance impairment by aniracetam , 1998 .
[44] Sang Joon Son,et al. Sundown Syndrome in Persons with Dementia: An Update , 2011, Psychiatry investigation.
[45] L. Burgio,et al. Studying disruptive vocalization and contextual factors in the nursing home using computer-assisted real-time observation. , 1994, Journal of gerontology.
[46] D J Foley,et al. Sleep complaints among elderly persons: an epidemiologic study of three communities. , 1995, Sleep.
[47] Randy J. Nelson,et al. Dim light at night provokes depression-like behaviors and reduces CA1 dendritic spine density in female hamsters , 2011, Psychoneuroendocrinology.
[48] I. Weiner,et al. Scopolamine Induces Disruption of Latent Inhibition which is Prevented by Antipsychotic Drugs and an Acetylcholinesterase Inhibitor , 2007, Neuropsychopharmacology.
[49] P. Mcgeer,et al. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain , 1984, Neurology.
[50] R. J. Rodgers,et al. Effects of scopolamine and its quaternary analogue in the murine elevated plus‐maze test of anxiety , 1995, Behavioural pharmacology.
[51] Richard E. Kronauer,et al. Dose-response relationships for resetting of human circadian clock by light , 1996, Nature.
[52] Kathryn A. Lee,et al. Sleep and “sundowning” in nursing home patients with dementia , 1993, Psychiatry Research.
[53] L. Burgio,et al. Temporal patterns of disruptive vocalization in elderly nursing home residents , 2001, International journal of geriatric psychiatry.
[54] H. Nygaard,et al. Improvement in sundowning in dementia with Lewy bodies after treatment with donepezil , 2000, International journal of geriatric psychiatry.
[55] A. Satlin,et al. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. , 1992, The American journal of psychiatry.
[56] S. Engelborghs,et al. Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances , 2004, The European journal of neuroscience.
[57] Jeanne F Duffy,et al. Light Exposure Patterns in Healthy Older and Young Adults , 2010, Journal of biological rhythms.
[58] B. Boeve,et al. Sleep Disturbance in Dementia with Lewy Bodies and Alzheimer’s Disease: A Multicenter Analysis , 2011, Dementia and Geriatric Cognitive Disorders.
[59] S. Ancoli-Israel,et al. CIRCADIAN RHYTHMS OF AGITATION IN INSTITUTIONALIZED PATIENTS WITH ALZHEIMER'S DISEASE , 2000, Chronobiology international.
[60] S. Finkel,et al. Introduction to behavioural and psychological symptoms of dementia (BPSD) , 2000, International journal of geriatric psychiatry.
[61] B. V. van Munster,et al. Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review , 2010, International journal of geriatric psychiatry.
[62] D. Swaab,et al. The human pineal gland and melatonin in aging and Alzheimer's disease , 2005, Journal of pineal research.
[63] Gill Livingston,et al. Anxiety and depression in family caregivers of people with Alzheimer disease: the LASER-AD study. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[64] LuAnn Nowak,et al. A qualitative examination of the phenomenon of sundowning. , 2007, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.
[65] P. Rabins,et al. "Sundowning" and other temporally associated agitation states in dementia patients. , 2006, Annual review of medicine.
[66] R. Hébert,et al. The contribution of neuropsychiatric symptoms to the cost of dementia care , 2006, International journal of geriatric psychiatry.
[67] G. ÓLaighin,et al. Validating a new clinical subtyping scheme for delirium with electronic motion analysis , 2010, Psychiatry Research.
[68] Jiska Cohen-Mansfield,et al. Temporal patterns of agitation in dementia. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[69] F. Pasquier,et al. Sundowning syndrome in demented patients without neuroleptic therapy. , 1996, Archives of gerontology and geriatrics.
[70] J. Szyndler,et al. The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia , 2000, Journal of Neural Transmission.
[71] C. McClung,et al. Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges , 2009, Brain Research Reviews.
[72] M. Mattson,et al. 3xTgAD mice exhibit altered behavior and elevated Aβ after chronic mild social stress , 2012, Neurobiology of Aging.
[73] N. Tarrier,et al. Determinants of carer stress in Alzheimer's disease , 1998, International journal of geriatric psychiatry.
[74] Lon S Schneider,et al. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. , 2005, JAMA.
[75] D. Garfinkel,et al. Melatonin for treatment of sundowning in elderly persons with dementia - a preliminary study. , 2000, Archives of gerontology and geriatrics.
[76] J. Yesavage,et al. The Relations among Caregiver Stress, “Sundowning” Symptoms, and Cognitive Decline in Alzheimer's Disease , 1992, Journal of the American Geriatrics Society.
[77] D. Bonthron,et al. PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model , 1991, Cell.